Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of pain on depression, sleep, exercise tolerance, and quality of life in patients with nontuberculous mycobacterial pulmonary disease.
Mori K, Tabusadani M, Yamane K, Takao S, Kuroyama Y, Matsumura Y, Ono K, Kawahara K, Omatsu S, Fujiwara K, Furuuchi K, Morimoto K, Kimura H, Senjyu H. Mori K, et al. Among authors: omatsu s. Medicine (Baltimore). 2021 Jun 11;100(23):e26249. doi: 10.1097/MD.0000000000026249. Medicine (Baltimore). 2021. PMID: 34115015 Free PMC article.
Influence of chronic sputum symptoms on quality of life in patients with nontuberculous mycobacterial pulmonary disease: A cross-sectional study.
Yamane K, Furuuchi K, Tabusadani M, Takao S, Kuroyama Y, Matsumura Y, Mori K, Ono K, Kawahara K, Omatsu S, Toyoda Y, Fujiwara K, Morimoto K, Senjyu H. Yamane K, et al. Among authors: omatsu s. Respir Investig. 2022 Mar;60(2):277-283. doi: 10.1016/j.resinv.2021.09.011. Epub 2021 Nov 8. Respir Investig. 2022. PMID: 34764045
Decreased incremental shuttle walk test distance characterized by fibrocavitary lesions in non-tuberculous mycobacterial pulmonary disease.
Ono K, Tabusadani M, Yamane K, Takao S, Mori K, Matsumura Y, Kuroyama Y, Kawahara K, Omatsu S, Furuuchi K, Fujiwara K, Morimoto K, Kimura H, Senjyu H. Ono K, et al. Among authors: omatsu s. Expert Rev Respir Med. 2022 Apr;16(4):469-475. doi: 10.1080/17476348.2022.2049762. Epub 2022 Mar 9. Expert Rev Respir Med. 2022. PMID: 35245168
Clinical significance and safety of combined treatment with chemotherapy and pulmonary rehabilitation regarding health-related quality of life and physical function in nontuberculous mycobacterial pulmonary disease.
Omatsu S, Tabusadani M, Yamane K, Takao S, Kuroyama Y, Matsumura Y, Mori K, Ono K, Kawahara K, Senjyu H, Kozu R. Omatsu S, et al. Respir Investig. 2022 Sep;60(5):674-683. doi: 10.1016/j.resinv.2022.06.006. Epub 2022 Jul 14. Respir Investig. 2022. PMID: 35843830
16 results